阿斯利康与第一三共已与Summit Therapeutics达成临床合作，将测试其抗癌药物Datroway与Summit的ivonescimab联合使用，针对包括肺癌和乳腺癌在内的多种肿瘤类型。
AstraZeneca and Daiichi Sankyo have entered into a clinical collaboration with Summit Therapeutics to test their cancer drug, Datroway, in combination with Summit's ivonescimab across multiple tumour types, including lung and breast cancers.